Verastem (VSTM) Accumulated Expenses (2011 - 2026)

Verastem's Accumulated Expenses history runs 16 years deep, the most recent figure standing at $7.9 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 146.34% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $7.9 million (up 146.34% YoY), while the FY2025 annual figure was $54.0 million, up 16982.59% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $7.9 million, down from $54.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $54.0 million in Q4 2025, with the low at $6000.0 in Q1 2022.
• The 5-year median for Accumulated Expenses is $3.6 million (2023), against an average of $9.9 million.
• Peak annual rise in Accumulated Expenses reached 56450.0% in 2022, while the deepest fall reached 99.93% in 2022.
• Verastem's Accumulated Expenses stood at $3.8 million in 2022, then soared by 366.39% to $17.9 million in 2023, then slumped by 98.24% to $316000.0 in 2024, then jumped by 16982.59% to $54.0 million in 2025, then slumped by 85.35% to $7.9 million in 2026.
• Business Quant data shows VSTM's Accumulated Expenses at $7.9 million in Q1 2026, $54.0 million in Q4 2025, and $7.8 million in Q3 2025.